Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small molecule APIs to advance biocatalysis across pharma.
Codexis
Advertisement
Articles by Codexis
Britton Jimenez, SVP of Sales and Marketing at Codexis, explains how the ECO Synthesis® Manufacturing Platform overcomes the limitations in scalability and sustainability that currently challenge the RNA therapeutics industry.
Advertisement
Latest Updated Articles
Inside Codexis: Redefining Pharma BiocatalysisPublished: December 18th 2025 | Updated: January 14th 2026
- Inside Codexis: Redefining Pharma Biocatalysis
Published: December 18th 2025 | Updated: January 14th 2026
Advertisement
Advertisement
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
Next-Generation Modalities Drive New Antibody Discovery
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5